Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Jose J. Limon, Lomon So et al.|Nature Medicine|2010Cited by 338
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J. Lim, Bin Liu, Ramin Salehi‐Rad et al.|Cell Reports Medicine|2024Cited by 111
Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung CancerRui Li, Steven M. Dubinett, Ramin Salehi‐Rad et al.|Cancer Research|2021Cited by 98
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinomaJunhui Hu, Lily Wu, Yangjun Zhang et al.|Signal Transduction and Targeted Therapy|2023Cited by 76
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinomaSixue Liu, Roger S. Lo, Hannah M. Knochelmann et al.|Cell Reports Medicine|2021Cited by 57